A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone

NCT02531035 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1405

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus (T1DM)
High Level of Sugar (Glucose) in the Blood

Interventions

DRUG: Sotagliflozin
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]